Home›Companies›Biotech & Pharma›Tundra Targeted Therapeutics

Tundra Targeted Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 3, 2025·Suggest an edit

About Tundra Targeted Therapeutics

Tundra Targeted Therapeutics is a private company based in Madison, Wisconsin, incorporated in 2021 in Wisconsin. It has reported $443,500 raised in one offering on Form D since June 2025. Its chief executive is Jediah White.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 30, 2025Jun 3, 2025$443,500of $3.0M target9$49,278DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Tundra Targeted Therapeutics's Form D filed Jun 3, 2025.

JW
Jediah White
President and CEO
JM
Jeffrey Medin
Executive officer and director
JC
James Caragher
Executive officer
BO
Brian Olson
Executive officer and director

Sources

  1. SECTUNDRA TARGETED THERAPEUTICS, INC. filing history